Sale of Securities

ARROWHEAD PHARMACEUTICALS, INC. Filed 2025-12-15 Acc 0001628280-25-057066

Documents 1

2025-12-18 4 Director acquired 7,819 shares (grant or award)
2025-12-18 4 Director acquired 7,819 shares (grant or award)
2025-12-17 144 Sale of Securities
2025-12-16 144 Sale of Securities
2025-12-16 4 Chief Executive Officer sold 184,298 shares at an average $67.00 ($12,348,802)
2025-12-15 144 Sale of Securities
2025-12-05 144 Sale of Securities

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…